Modifications and accessories for Bruker Biospin MRI 7-T with Avance III

The Food and Drug Administration intends to conduct a non-competitive procurement with Doty Scientific, Inc. for Modifications and accessories for Bruker Biospin MRI 7-T with Avance III. A firm-fixed price award is anticipated following procurement procedures of FAR 13.5 - Test Program for Certain Commercial Items. The proposed contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302. This notice of intent is not a request for competitive proposals. However, all proposals received before the closing date of this synopsis will be considered by the Government. A determination by Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This is a 100% Small Business Set Aside. (ii) The solicitation number is 09-222-SOL-00159. This solicitation is issued as a Request for Quote (RFQ). (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-36, August 11, 2009. (iv) The associated North American Industry Classification System (NAICS) Code is 335999 - All Other Miscellaneous Electrical Equipment and Component Manufacturing, Small Business Size Standard 500 Employees. (v) The Food and Drug Administration is soliciting for supplies per the description as follows: Statement of Need: These technologies, tuned radio frequency coils, apparatuses and components must be specially created to accomplish subtle research refinement endeavors outlined for the NCTR and thus become compatible with existing instruments in order to generate immediate, dynamic data from the rat and monkey brain. These items are needed to refine and adapt the focal analysis capabilities of our on'site 7T Bruker Biospin MRI system to accomplish in vio, non invasive scanning performed to characterize MRI-specific transient and permanent neural responses via different kinds of intervention including chemical and biological compounds in larger animals (e.g. infant monkeys), rat, and mouse species testing subjects. Statement of Work: Experiments will be directed as neuro-imaging of live subjects and will be an ongoing study to characterize immediate neural expression and compound effect within brain structures of multiple species, as well as male and female gender differences. These animal models should correlate well with human effects. This endeavor will require the purchase of the following items: Modifications and Accessories for Bruker Biospin MRI 7-T with Avance III: . Litzcage small animal imaging system for rat brain: 38 mm coil dia. x 50 mm rung length RF region; quadrature tuning with Doty Litzcage for 1H at 300.3 MHz Removable RF shield for full access to sample region (10 cm OD). . Litzcage small animal imaging system: 63 mm dia. X 130 mm rung length; quadrature tuning with Doty Litzcage for single channel tuned to 1H at 300.3 MHz (7 T). Removable RF shield for full access to sample region (12 cm OD) . 12 mm diameter, Single-tuned (1H at 300 MHz), Transmit/Receive. . 24 mm diameter, Single-tuned (1H at 300 MHz), Transmit/Receive. . Remote Coil Matching Network for 300 MHz. An official authorized to bind the Offeror must sign the terms and conditions of the offer. Offerors that fail to finish required representations, and certifications, or reject the terms and conditions of the solicitation, may be excluded from consideration. (vi) Contract type: Commercial Item - Firm Fixed Price. Simplified procurement procedures will be utilized. (vii) The period of performance is 6 Months or less after receipt of order (ARO). FOB Point Destination. FOB Point of Delivery for Services and Supplies provided will be the Food and Drug Administration, NCTR, Jefferson Laboratories, 3900 NCTR Road, Jefferson, AR 72079-9502. (viii) The provision at FAR 52.212-1 Instructions to Offerors - Commercial Items applies to this solicitation. The following addenda have been attached to this provision: None. (x) Offerors must include a completed copy of the provision at FAR 52.212-3, Offeror Representations and Certifications - Commercial Items with its offer. Offers must be submitted on a SF-1449, which can be found at http://www.gsa.gov/Portal/gsa/ep/formslibrary.do?formType=SF (xii) The clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. The following addenda have been attached to the clause: None. (xii) The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes of Executive Orders - Commercial Items, applies to this acquisition. The following additional FAR clauses cited in this clause are applicable: 52.219-4, 52.219-6, 52.219-28, 52.222-3, 52.222-19, 52.222-21, 52.222-26, 52.222-36, 52.225-1, 52.225-3 ALT I, 52.225-13, and 52.232-33. Clauses and provisions are incorporated by reference and apply to this acquisition. Clauses and provisions can be obtained at http://www.acquisition.gov. It is the offerors responsibility to monitor the FedBizOpps website for any released amendments to the solicitation. CCR Requirement - Company must be registered on Central Contractor Registration (CCR) before an award could be made to them. If company is not registered in CCR, they may do so by going to CCR web site at http://www.ccr.gov. (xiii) A standard commercial warranty on parts and workmanship is required. (xiv) The Defense Priorities and Allocations System (DPAS) and assigned rating are not applicable to this solicitation notice. (xv) Applicable Numbered Note(s) (xvi) The proposal must reference solicitation number 09-222-SOL-00159. The Offers are due in person, by mail, e-mail, or fax on or before September 12, 2009 by 3:30 P.M. (Central Standard Time - Local Prevailing Time in Jefferson, Arkansas), at the Food and Drug Administration OC/OSS/OAGS 3900 NCTR Road, Jefferson, AR 72079-9502. (xvii) For information regarding this solicitation, please contact Barbara Arnold @ (870) 543-7483, FAX (870) 543-7990, email barbara.arnold@fda.hhs.gov.